Table 5.
Biomarkers for intracerebral hemorrhage
| Authors/year/Ref | Study design | Population | N | Bio-marker | Sample source | Findings |
|---|---|---|---|---|---|---|
| Molecules of CNS origin | ||||||
| Hu/2012/[132] | Pro | Basal ganglia ICH within 6 h of onset | 176 | Tau | Serum |
|
| Hu/2010/[127] | Pro | Basal ganglia ICH | 86 ICH, 30 CTRL | s100β | Plasma |
|
| Delgado/2006/[126] | Pro | ICH | 78 | s100β | Blood |
|
| Brea/2009/[129] | Pro | ICH and AIS | 44 ICH, 224 AIS | NSE | Blood |
|
| James/2009/[128] | Pro | ICH | 28 | s100β, BNP | Blood |
|
| Cai/2013/[133] | Case control | Basal ganglia ICH | 112 ICH, 112 CTRL | pNF-H | Plasma |
|
| Biomarkers of inflammation | ||||||
| Leira/2004/[137] | Pro | ICH within 12 h of onset | 266 | Neutrophils, fibrinogen | Blood |
|
| Di Napoli/2011/[135] | Pro | ICH | 210 | WBC, CRP, Glucose | Blood |
|
| Agnihotri/2011/[136] | Retro | Spontaneous ICH | 423 | WBC | Blood |
|
| Zhao/2013/[149] | Pro | Basal ganglia ICH within 6 h of onset | 132 ICH, 68 CTRL | pGSN | Plasma |
|
| Castillo/2002/[134] | Pro | ICH within 24 h of onset | 124 | Glutamate, TNFα | Blood |
|
| Wang/2011/[139] | Pro Posthoc analysis | ICH within 24 h of onset | 60 | sICAM-1, sE-selectin | Plasma |
|
| Li/2013/[148] | Pro | ICH within 24 h of onset | 59 | MMP-3, MMP-9 | Plasma |
|
| Hernandez-Guillamon/2012/[140] | Pro | ICH within 48 h of onset | 66 ICH, 58 CTRL | VAP-1/SSAO | Plasma |
|
| Fang/2005/[141] | Pro | ICH | 43 | IL-11 | Plasma |
|
| Diedler/2009/[138] | Retro | Supratentorial ICH | 113 | CRP | Blood |
|
| Gu/2013/[142] | Pro | Basal ganglia ICH within 6 h of onset | 85 ICH, 85 CTRL | Visfatin | Plasma |
|
| Huang/2013/[143] | Case control | Basal ganglia ICH | 128 ICH, 128 CTRL | Visfatin | Plasma |
|
| Zhang/2013/[144] | Pro | Basal ganglia ICH | 92 ICH, 50 CTRL | Leptin | Plasma |
|
| Other biomarkers | ||||||
| Chiu/2012/[150] | Pro | ICH within 24 h of onset, >16 years old | 170 | d-dimer | Serum |
|
| Delgado/2006/[126] | Pro | ICH | 98 | d-dimer | Plasma |
|
| Rodriguez-Luna/2011/[151] | Pro | Supratentorial ICH within 6 h of onset | 108 | LDL-C | Serum |
|
| Ramirez-Moreno/2009/[152] | Pro | ICH within 12 h of onset | 88 | LDL-C | Serum |
|
| Hays/2006/[153] | Retro | ICH | 235 | cTn1 | Blood |
|
| Chen/2011/[158] | Pro | ICH | 64 ICH, 114 CTRL | Oxidative markers | Blood |
|
| Wang/2012/[155] | Pro | ICH within 24 h of onset | 60 ICH, 60 CTRL | Nuclear DNA | Plasma |
|
| Huang/2009/[154] | Pro | Basal ganglia ICH | 36 ICH, 10 CTRL | Microparticles | Plasma, CSF |
|
| Zheng/2012/[156] | Case control | ICH | 79 | miRNAs | Blood |
|
| Zhang/2012/[157] | Pro | Basal ganglia ICH | 89 ICH, 50 CTRL | Copeptin | Plasma |
|
Pro prospective observational, RCT randomized controlled trial, Retro retrospective, CTRL control subjects, OR odds ratio